SEGMENT INFORMATION - Profitability (Details) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Apr. 30, 2016
USD ($)
|
Apr. 30, 2015
USD ($)
|
Apr. 30, 2016
USD ($)
|
Apr. 30, 2015
USD ($)
|
|
Segment Reporting [Abstract] | ||||
Number of operating segments | 3 | |||
Select Income Statement Components | ||||
Total net revenue | $ 1,019 | $ 963 | $ 2,047 | $ 1,989 |
Income from operations | 131 | 107 | 286 | 222 |
Life Sciences and Applied Markets | ||||
Select Income Statement Components | ||||
Total net revenue | 495 | 473 | 1,021 | 1,020 |
Income from operations | 94 | 75 | 208 | 182 |
Diagnostics and Genomics | ||||
Select Income Statement Components | ||||
Total net revenue | 178 | 169 | 336 | 317 |
Income from operations | 27 | 25 | 42 | 26 |
Agilent CrossLab | ||||
Select Income Statement Components | ||||
Total net revenue | 346 | 321 | 690 | 652 |
Income from operations | 74 | 69 | 150 | 137 |
Segment Total | ||||
Select Income Statement Components | ||||
Total net revenue | 1,019 | 963 | 2,047 | 1,989 |
Income from operations | $ 195 | $ 169 | $ 400 | $ 345 |